These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5256940)

  • 1. [Chromosome aberrations induced by myleran in human leukocytes in vitro].
    Gebhart E
    Humangenetik; 1969; 7(2):126-36. PubMed ID: 5256940
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on busulfan (myleran) treated leukocyte cultures. I. Cytological observations.
    Richmond JY; Kaufmann BN
    Exp Cell Res; 1969 Mar; 54(3):377-80. PubMed ID: 5777432
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromosome changes in patients treated with "Myleran".
    Krajincanić B; Lazarov A; Zunić Z; Radojicić B
    Strahlentherapie; 1976 May; 151(5):459-62. PubMed ID: 1064182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the influence of myleran on human chromosomes through L-cysteine].
    Gebhart E
    Mutat Res; 1969; 7(2):254-7. PubMed ID: 5796523
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytogenetic effect of vincristine on human leukocytes in vivo and in vitro].
    Gebhart E; Schwanitz G; Hartwich G
    Med Klin; 1969 Dec; 64(51):2366-71. PubMed ID: 5266098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chromosome changes in myleran therapy].
    Gebhardt E; Schwanitz G; Hartwich H
    Verh Dtsch Ges Inn Med; 1973; 79():1389-91. PubMed ID: 4524449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Localization and distribution of myleran-induced chromosome breaks in Vicia faba. I. The effect of 5-bromodeoxyuridine on chromosome aberration rate].
    Keller R
    Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1968; 43(3-4):suppl 105-12. PubMed ID: 5761622
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of G1 phase of the mitotic cycle to chromosome aberrations induced by daunomycin.
    Vig BK; Kontras SB; Aubele AM
    Mutat Res; 1969; 7(1):91-7. PubMed ID: 5801079
    [No Abstract]   [Full Text] [Related]  

  • 9. [Distribution of aberrations after treatment of human chromosomes with Myleran in vitro].
    Gebhart E
    Chromosoma; 1970; 29(3):336-48. PubMed ID: 5436405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlymphocytosis in a case of busulfan-induced medullar aplasia in chronic myeloid leukemia. Chromosome and functional study].
    Negrini AC; Azzolini A; Bertocchi I; Dolcino G
    Pathologica; 1967; 59(879):407-10. PubMed ID: 5273096
    [No Abstract]   [Full Text] [Related]  

  • 11. Busulfan treatment in pregnancy. A case report with chromosome studies.
    Uhl N; Eberle P; Quellhorst E; Schmidt R; Hunstein W
    Ger Med Mon; 1969 Aug; 14(8):383-7. PubMed ID: 5260016
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetic anomalies in a child born to a mother receiving busulfan for chronic myeloid leukaemia.
    Bhisey AN; Advani SH; Khare AG
    Indian J Cancer; 1982; 19(5):272-6. PubMed ID: 6219940
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of daunomycin on human cells in vivo and in vitro.
    Whang-Peng J; Leventhal BG; Adamson JW; Perry S
    Cancer; 1969 Jan; 23(1):113-21. PubMed ID: 5249421
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of sister chromatid exchanges and chromosomal aberrations by busulfan in Philadelphia chromosome-positive chronic myeloid leukemia and normal bone marrow.
    Becher R; Prescher G
    Cancer Res; 1988 Jun; 48(12):3435-9. PubMed ID: 3163516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
    Etcheberry R; Becker P; Delmastro J; Donoso S
    Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E; Schwanitz G; Hartwich G
    Dtsch Med Wochenschr; 1974 Jan; 99(2):52-56. PubMed ID: 4520646
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous pigmentations during myeloid leukemia treated with myleran].
    Marchal G; Bilski-Pasquier G; Maunand
    Sem Ther; 1963 Nov; 39(9):565-8. PubMed ID: 5230097
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytogenetic effects of myleran in vivo on bone-marrow cells from male mice.
    Léonard A; Léonard ED
    Mutat Res; 1978 Jan; 56(3):329-33. PubMed ID: 625305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: The Philadelphia chromosome and chronic myelocytic leukemia (CML) --still a complex relationship?
    Gahrton G; Lindsten J; Zech L
    Acta Med Scand; 1974 Nov; 196(5):353-4. PubMed ID: 4531215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J; Muratore R; Gabriel B; Canu AM
    Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.